p16 as a biomarker to distinguish atypical ductal hyperplasia from ductal carcinoma in situ and to predict breast cancer progression

TY - JOUR

T1 - p16 as a biomarker to distinguish atypical ductal hyperplasia from ductal carcinoma in situ and to predict breast cancer progression

AU - Tjoe, Judy A

AU - Last, Brittany S

AU - Yin, Jun

AU - Ob/Gyn Faculty, Aurora

N1 - Tjoe J, Last B, Yin J. p16 as a biomarker to distinguish atypical ductal hyperplasia from ductal carcinoma in situ and to predict breast cancer progression. Ann Surg Oncol 2019;26(2 Suppl):53. doi: 10.1245/s10434-019-07407-7.

PY - 2019/5/2

Y1 - 2019/5/2

KW - ACH

KW - DCIS

UR - https://institutionalrepository.aah.org/obgynfaculty/34

UR - https://liblynxgateway.com/aah?url=https://link.springer.com/article/10.1245/s10434-019-07407-7

U2 - 10.1245/s10434-019-07407-7

DO - 10.1245/s10434-019-07407-7

M3 - Meeting abstract

JO - Annals of surgical oncology

JF - Annals of surgical oncology

ER -